DK3104839T3 - Topiske formuleringer af heparin - Google Patents

Topiske formuleringer af heparin Download PDF

Info

Publication number
DK3104839T3
DK3104839T3 DK15710252.6T DK15710252T DK3104839T3 DK 3104839 T3 DK3104839 T3 DK 3104839T3 DK 15710252 T DK15710252 T DK 15710252T DK 3104839 T3 DK3104839 T3 DK 3104839T3
Authority
DK
Denmark
Prior art keywords
heparin
topical formulations
topical
formulations
Prior art date
Application number
DK15710252.6T
Other languages
English (en)
Inventor
Ketan Rajnikant Patel
Milan Rajnikant Patel
Asheel Ketan Patel
Prakash Jayantilal Shah
Original Assignee
Troikaa Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52684592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3104839(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Troikaa Pharmaceuticals Ltd filed Critical Troikaa Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK3104839T3 publication Critical patent/DK3104839T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK15710252.6T 2014-02-10 2015-02-10 Topiske formuleringer af heparin DK3104839T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN475MU2014 2014-02-10
PCT/IB2015/050986 WO2015118512A1 (en) 2014-02-10 2015-02-10 Topical formulations of heparin

Publications (1)

Publication Number Publication Date
DK3104839T3 true DK3104839T3 (da) 2020-01-20

Family

ID=52684592

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15710252.6T DK3104839T3 (da) 2014-02-10 2015-02-10 Topiske formuleringer af heparin

Country Status (25)

Country Link
US (1) US9861655B2 (da)
EP (1) EP3104839B1 (da)
JP (1) JP6275877B2 (da)
KR (1) KR101822133B1 (da)
CN (1) CN106163498A (da)
AP (1) AP2016009350A0 (da)
AR (1) AR099333A1 (da)
AU (1) AU2015213569B2 (da)
CA (1) CA2938388C (da)
CL (1) CL2016001952A1 (da)
CU (1) CU24444B1 (da)
DK (1) DK3104839T3 (da)
DO (1) DOP2016000198A (da)
EA (1) EA032200B1 (da)
EC (1) ECSP16069947A (da)
IL (1) IL246974B (da)
MA (1) MA39304B1 (da)
MX (1) MX357765B (da)
MY (1) MY182620A (da)
NZ (1) NZ722830A (da)
PE (1) PE20161173A1 (da)
PH (1) PH12016501500B1 (da)
TW (1) TWI538697B (da)
UA (1) UA118279C2 (da)
WO (1) WO2015118512A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101955175B1 (ko) * 2010-04-13 2019-03-06 나지브 바불 1-메틸-2'-6'-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
CN112546061B (zh) * 2021-02-25 2021-06-11 中南大学湘雅医院 一种肝素类药物组合物、喷鼻剂及其制备方法及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323389A1 (de) * 1983-06-29 1985-01-10 B. Braun Melsungen Ag, 3508 Melsungen Auf schleimhaeute des mundes, der nase und/oder des rachens wirkende arzneimittel auf der basis von heparin und tensiden
JPH02207018A (ja) * 1989-02-07 1990-08-16 Kao Corp 皮膚外用剤
DE19536246A1 (de) 1994-09-30 1996-04-04 Juergen Dr Regenold Pharmazeutische Zusammensetzung
IT1275955B1 (it) 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
JPH10279466A (ja) * 1997-04-07 1998-10-20 Kose Corp 外用剤
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
BRPI0101486B1 (pt) 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
JP5694665B2 (ja) * 2006-11-15 2015-04-01 アースリティス レリーフ プラス エル ティー ディーＡｒｔｈｒｉｔｉｓ Ｒｅｌｉｅｆ Ｐｌｕｓ Ｌｔｄ 局所製剤とその用法
IT1400232B1 (it) * 2010-05-07 2013-05-24 Advance Holdings Ltd Composizione farmaceutica topica comprendente eparina
AU2012236493A1 (en) * 2011-04-01 2013-10-31 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics

Also Published As

Publication number Publication date
EP3104839A1 (en) 2016-12-21
DOP2016000198A (es) 2016-10-31
EP3104839B1 (en) 2019-11-13
PH12016501500A1 (en) 2017-02-06
AR099333A1 (es) 2016-07-13
US20170165291A1 (en) 2017-06-15
ECSP16069947A (es) 2018-06-30
MA39304B1 (fr) 2018-12-31
AU2015213569B2 (en) 2018-01-04
WO2015118512A1 (en) 2015-08-13
UA118279C2 (uk) 2018-12-26
KR20160117529A (ko) 2016-10-10
JP2017505344A (ja) 2017-02-16
PH12016501500B1 (en) 2017-02-06
CU20160119A7 (es) 2016-10-28
US9861655B2 (en) 2018-01-09
PE20161173A1 (es) 2016-10-27
AU2015213569A1 (en) 2016-08-18
MX2016010399A (es) 2017-02-23
MX357765B (es) 2018-07-23
IL246974B (en) 2018-07-31
KR101822133B1 (ko) 2018-01-25
CU24444B1 (es) 2019-10-04
NZ722830A (en) 2018-01-26
MA39304A1 (fr) 2018-01-31
AP2016009350A0 (en) 2016-07-31
MY182620A (en) 2021-01-27
CN106163498A (zh) 2016-11-23
EA032200B1 (ru) 2019-04-30
TWI538697B (zh) 2016-06-21
EA201691596A1 (ru) 2017-01-30
CL2016001952A1 (es) 2017-03-10
JP6275877B2 (ja) 2018-02-07
TW201532631A (zh) 2015-09-01
CA2938388C (en) 2018-07-17
CA2938388A1 (en) 2015-08-13

Similar Documents

Publication Publication Date Title
FIC20230006I1 (fi) Vutrisiraani
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3283625T3 (da) Nukleasemedieret genomeditering
DK3361870T3 (da) Fungicidsammensætninger
DK3305788T3 (da) Janus-kinase-hæmmer
DK3277719T3 (da) Polypeptider
DK3331528T3 (da) Muskarinagonister
DK3310450T3 (da) Olie-vand-separator
DK3334726T3 (da) Plinabulinsammensætninger
DK3331529T3 (da) Muskarinagonister
DK3283210T3 (da) Fremgangsmåde
DK3307267T3 (da) Behandling af multipel sklerose
DK3250182T3 (da) Dispergible sammensætninger
DK3270930T3 (da) Præeklampsi
KR20180084915A (ko) 구조체
DK3296597T3 (da) Krydshovedmotor
DK3368044T3 (da) Behandling af hepatisk steatose-relateret oligo-ovulation
DK3292136T3 (da) Penicillin-g-acylaser
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
DK3316857T3 (da) Multifasiske sammensætninger
DE112015006486A5 (de) Inkubationsrinne
DK3418273T3 (da) Derivater af flavagliner
DK3113773T3 (da) Krystallinske former af grapiprant
DK3318308T3 (da) Badmintonketsjer
DK3274482T3 (da) Stenborsknop